New CRO unit facility welcomes first overnight patients
Posted:
31
March 2017
Richmond Pharmacology has been busy settling in their first patients at the new London Bridge site.
New CRO unit facility welcomes first overnight patients
One month on from Richmond's opening event, which saw leading industry bodies and stakeholders convene, the CRO has been busy settling in their first patients at the new London Bridge site.Clinical work commenced on the 25th March with volunteers commenting on the excellent transport links and fantastic new location in the heart of London Bridge.
Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations
April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Richmond Pharmacology announces CEO Dr. Jorg Taubel's appointment as President Elect of Germany's AGAH, where he will enhance early-phase clinical research over a six-year term.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.